New Zealand’s largest refiner and blender of high-quality internationally-certified concentrated fish oils and fractions SeaDragon today advises it has begun a transition to new leadership.
Read more about Leadership changes at SeaDragon
AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced that Scott Salka has been appointed as the new CEO.
Read more about AmpliPhi Biosciences Announces M. Scott Salka as New CEO
By Nigel Roberts. April 28 2015. Link here.